20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
Private Equity thrives on unlocking value in portfolio companies through governance improvements and strategic interventions. Yet, as economic and market complexities increase, the challenge of…
Read more
Despite huge efforts to improve operational processes over the past 20 years, critically important management processes are left up to the discretion of each manager…
Read more
The global economy in 2024 resembles a rollercoaster more than ever before. Geopolitical tensions, technological disruptions, and shifting consumer behaviours have created a perfect storm…
Read more
Erhalten Sie jeden Monat Neuigkeiten und wertvolle Perspektiven zu Themen der organisatorischen Effektivität
